238 related articles for article (PubMed ID: 10699323)
1. CpG DNA induces stronger immune responses with less toxicity than other adjuvants.
Weeratna RD; McCluskie MJ; Xu Y; Davis HL
Vaccine; 2000 Mar; 18(17):1755-62. PubMed ID: 10699323
[TBL] [Abstract][Full Text] [Related]
2. CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice.
Weeratna RD; Brazolot Millan CL; McCluskie MJ; Davis HL
FEMS Immunol Med Microbiol; 2001 Dec; 32(1):65-71. PubMed ID: 11750224
[TBL] [Abstract][Full Text] [Related]
3. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen.
Davis HL; Weeratna R; Waldschmidt TJ; Tygrett L; Schorr J; Krieg AM
J Immunol; 1998 Jan; 160(2):870-6. PubMed ID: 9551923
[TBL] [Abstract][Full Text] [Related]
4. CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice.
McCluskie MJ; Davis HL
J Immunol; 1998 Nov; 161(9):4463-6. PubMed ID: 9794366
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of novel aggregate structures as adjuvants: composition, toxicity studies and humoral responses.
Rajananthanan P; Attard GS; Sheikh NA; Morrow WJ
Vaccine; 1999 Feb; 17(7-8):715-30. PubMed ID: 10067677
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of several adjuvants as alternatives to the use of Freund's adjuvant in rabbits.
Leenaars PP; Hendriksen CF; Angulo AF; Koedam MA; Claassen E
Vet Immunol Immunopathol; 1994 Mar; 40(3):225-41. PubMed ID: 8160361
[TBL] [Abstract][Full Text] [Related]
7. A CpG-containing oligodeoxynucleotide as an efficient adjuvant counterbalancing the Th1/Th2 immune response in diphtheria-tetanus-pertussis vaccine.
Sugai T; Mori M; Nakazawa M; Ichino M; Naruto T; Kobayashi N; Kobayashi Y; Minami M; Yokota S
Vaccine; 2005 Nov; 23(46-47):5450-6. PubMed ID: 16006019
[TBL] [Abstract][Full Text] [Related]
8. CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice.
Brazolot Millan CL; Weeratna R; Krieg AM; Siegrist CA; Davis HL
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15553-8. PubMed ID: 9861007
[TBL] [Abstract][Full Text] [Related]
9. CpG-DNA stimulates cellular and humoral immunity and promotes Th1 differentiation in aged BALB/c mice.
Maletto B; Rópolo A; Morón V; Pistoresi-Palencia MC
J Leukoc Biol; 2002 Sep; 72(3):447-54. PubMed ID: 12223511
[TBL] [Abstract][Full Text] [Related]
10. Plasmid DNA containing multiple CpG motifs triggers a strong immune response to hepatitis B surface antigen when combined with incomplete Freund's adjuvant but not aluminum hydroxide.
Luo Z; Shi H; Zhang H; Li M; Zhao Y; Zhang J; Guo F; Luo S; Sun P; Zhang D; Qian Z; Yang L
Mol Med Rep; 2012 Dec; 6(6):1309-14. PubMed ID: 22971976
[TBL] [Abstract][Full Text] [Related]
11. Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses.
Bian G; Cheng Y; Wang Z; Hu Y; Zhang X; Wu M; Chen Z; Shi B; Sun S; Shen Y; Chen EJ; Yao X; Wen Y; Yuan Z
Vaccine; 2009 Dec; 28(1):187-94. PubMed ID: 19789093
[TBL] [Abstract][Full Text] [Related]
12. Immunization with the Haemophilus ducreyi trimeric autotransporter adhesin DsrA with alum, CpG or imiquimod generates a persistent humoral immune response that recognizes the bacterial surface.
Samo M; Choudhary NR; Riebe KJ; Shterev I; Staats HF; Sempowski GD; Leduc I
Vaccine; 2016 Feb; 34(9):1193-200. PubMed ID: 26812077
[TBL] [Abstract][Full Text] [Related]
13. Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA.
McCluskie MJ; Weeratna RD; Payette PJ; Davis HL
FEMS Immunol Med Microbiol; 2002 Feb; 32(3):179-85. PubMed ID: 11934561
[TBL] [Abstract][Full Text] [Related]
14. Archaeosome vaccine adjuvants induce strong humoral, cell-mediated, and memory responses: comparison to conventional liposomes and alum.
Krishnan L; Dicaire CJ; Patel GB; Sprott GD
Infect Immun; 2000 Jan; 68(1):54-63. PubMed ID: 10603368
[TBL] [Abstract][Full Text] [Related]
15. Immune responses to hepatitis B surface antigen following epidermal powder immunization.
Osorio JE; Zuleger CL; Burger M; Chu Q; Payne LG; Chen D
Immunol Cell Biol; 2003 Feb; 81(1):52-8. PubMed ID: 12534946
[TBL] [Abstract][Full Text] [Related]
16. Prototype Alzheimer's disease epitope vaccine induced strong Th2-type anti-Abeta antibody response with Alum to Quil A adjuvant switch.
Ghochikyan A; Mkrtichyan M; Petrushina I; Movsesyan N; Karapetyan A; Cribbs DH; Agadjanyan MG
Vaccine; 2006 Mar; 24(13):2275-82. PubMed ID: 16368167
[TBL] [Abstract][Full Text] [Related]
17. Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen.
Mutwiri G; Benjamin P; Soita H; Babiuk LA
Vaccine; 2008 May; 26(22):2680-8. PubMed ID: 18430493
[TBL] [Abstract][Full Text] [Related]
18. The Combination Vaccine Adjuvant System Alum/c-di-AMP Results in Quantitative and Qualitative Enhanced Immune Responses Post Immunization.
Ebensen T; Delandre S; Prochnow B; Guzmán CA; Schulze K
Front Cell Infect Microbiol; 2019; 9():31. PubMed ID: 30838180
[TBL] [Abstract][Full Text] [Related]
19. Modulation of gene-gun-mediated Th2 immunity to hepatitis B surface antigen by bacterial CpG motifs or IL-12.
Schirmbeck R; Reimann J
Intervirology; 2001; 44(2-3):115-23. PubMed ID: 11509872
[TBL] [Abstract][Full Text] [Related]
20. Polycation-decorated PLA microspheres induce robust immune responses via commonly used parenteral administration routes.
Chen X; Wang L; Liu Q; Jia J; Liu Y; Zhang W; Ma G; Su Z
Int Immunopharmacol; 2014 Dec; 23(2):592-602. PubMed ID: 25466267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
